Molecular profiling of afatinib-resistant non-small cell lung cancer cells in vivo derived from mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular profiling of afatinib-resistant non-small cell lung cancer cells in vivo derived from mice

Published:2020-11 Issue: Volume:161 Page:105183
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Chung Cheng-Ta,Yeh Kai-Chia,Lee Chia-Huei,Chen Yun-Yu,Ho Pai-Jiun,Chang Kai-Yen,Chen Chieh-Hsin,Lai Yiu-Kay,Chen Chiung-Tong

Funder

Ministry of Science and Technology, Taiwan

National Health Research Institutes

National Science Council

Publisher

Elsevier BV

Subject

Pharmacology

Reference96 articles.

1. The new World Health Organization classification of lung tumours;Brambilla;Eur. Respir. J.,2001

2. EGFR and cancer prognosis;Nicholson;Eur. J. Cancer,2001

3. Tyrosine kinases as targets for cancer therapy;Krause;N. Engl. J. Med.,2005

4. Epidermal growth factor receptor: mechanisms of activation and signalling;Jorissen;Exp. Cell Res.,2003

5. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis;Hirsch;J. Clin. Oncol.,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TM4SF19 controls GABP-dependent YAP transcription in head and neck cancer under oxidative stress conditions;Proceedings of the National Academy of Sciences;2024-02-05

2. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy;Molecular Cancer;2023-11-28

3. Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer;Cancers;2023-06-22

4. Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC);Disease Markers;2022-09-14

5. A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients;Computers in Biology and Medicine;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3